
Google's Related Medications Feature Can't Replace Pharmacists
Google's new related medications feature might lead patients to mistakenly believe that they don't need to seek drug information from their pharmacist.
Google’s new related medications feature might lead patients to mistakenly believe that they don’t need to seek drug information from their pharmacist.
When an individual uses the search engine to investigate a particular drug, related medications may now appear directly below the standard medical knowledge panel. If one of the related medications is clicked, the user is redirected to the medical knowledge panel for that drug.
Here’s an example:
In this instance, searching “ibuprofen” through Google triggered the related medications feature, which listed other nonsteroidal anti-inflammatory drugs such as bromfenac (Xibrom), meloxicam (Mobic), and mefenamic acid (Ponstel).
Although this function is not yet available for all medications, searching for many of the
More than one-third of US adults regularly use the Internet to
Nevertheless, providing patients with more information about their medication options is objectively a good thing, and Google’s related medications feature highlights the search engine’s commitment to providing accurate medical information. In a blog post, Google said it has blocked more than 12.5 million unregulated drug ads that it considered to be in violation of its health care and medicines policy for making “misleading claims to be as effective as prescription drugs.”
Pharmacists should discuss new search capabilities with patients and remind them to continue consulting with them or another health care professional on any medication-related questions.
“We have more tools and resources now than ever, and because of the Web, people can connect to information quickly, so we must reevaluate our methods of patient engagement and counseling,” Ronelle E. Stevens, PharmD, RPh, CACP,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































